Ozempic: cost, evidence, and the honest comparison

The same molecule as Wegovy — semaglutide — but labelled, dosed, and studied for blood-sugar control in type 2 diabetes rather than for weight management.

Read this first: If you are researching weight loss, the approved options are Wegovy, Zepbound, and Foundayo. We publish Ozempic pricing for people prescribed it for type 2 diabetes and for accurate market comparison, and we deliberately exclude it from our weight-loss tools.

What it's approved for

Type 2 diabetes — improving blood sugar alongside diet and exercise, and reducing cardiovascular risk in adults with type 2 diabetes and known heart disease. Ozempic is NOT approved for weight loss.

What the research actually shows

Weight change is a well-documented effect in its diabetes trials, which is why the drug became famous. That does not make it an approved weight-loss product: the FDA-approved semaglutide options for weight management are Wegovy's pen and pill.

Sources: FDA label information (DailyMed)

Side effects, stated plainly

Gastrointestinal effects are most common; the label carries the class boxed warning regarding thyroid C-cell tumours in rodents. Your prescriber and the label are the authority here.

What it costs

Cash pricing through the manufacturer's pharmacy runs $349 a month up to the 1 mg dose and $499 at 2 mg, with an oral version from $149. We track it because people shopping this market compare it — not because we think weight-loss shoppers should be steered to it.

ChannelForm & doseMedRequired feeTrue monthlyStatus
NovoCare PharmacyLOWEST LISTED pill · low dose $149 $149 listed
NovoCare Pharmacy pill · mid dose $199 $199 listed
NovoCare Pharmacy pill · high dose $299 $299 listed
NovoCare Pharmacy pen · up to 1 mg $349 $349 listed
NovoCare Pharmacy pen · 2 mg $499 $499 listed

True monthly = medication plus any required membership fee. Cheapest listed right now: NovoCare Pharmacy at $149/month. Full table and filters on the Ozempic cost page.

Keep reading

Common questions

Can I get Ozempic for weight loss?

Ozempic is approved for type 2 diabetes, not weight management. Prescribing decisions belong to clinicians, but the FDA-approved semaglutide products for weight loss are Wegovy's pen and pill, and our weight-loss tools point there for that reason.

Other weight loss medications

Wegovy · Zepbound · Foundayo · Compounded semaglutide · Compounded tirzepatide · Liraglutide

Ozempic market news

2026-07-29
FTC, Utah, and LA County sue Hims & Hers over health-data sharing and cancellation practices

The complaint targets sharing sensitive health data with ad platforms and ROSCA billing/cancellation practices — context for anyone weighing the $149/month membership model.

The Hims dossier →
2026-07-01
Medicare's $50/month GLP-1 Bridge copay goes live

Participating Part D plans now cover Wegovy (pen and pill), Foundayo, and the Zepbound KwikPen at a flat $50 monthly copay through 2027 — below every cash price we track.

How the Bridge actually works →
2026-04-30
FDA moves to permanently end bulk compounding of semaglutide and tirzepatide

The proposed 503B Bulks List exclusion would close the mass-compounding era for good. Patient-specific 503A compounding continues — the legal market our index tracks at $139–$297 all-in.

The surviving market, explained →

All tracked news → · Fed by a daily automated scan; entries publish only after primary-source verification.

Educational and pricing journalism, not medical advice — indications, dosing, and suitability are decisions for you and a licensed clinician, and the FDA label is the authority on risks. Prices carry the verification dates shown; the provider's checkout is the final word. Some links may earn commissions; rankings are ordered by cost, never compensation — disclosure.

Prices here change monthly. Get one email when they do. Free price-drop alerts →